Xconomy

JULY 9, 2018

venture capital investments swelled to a level not seen since the dot-com era of the early 2000s. companies through the first six months of 2018, according to the latest Venture Monitor report produced quarterly by Seattle-based PitchBook and the National Venture Capital Association (NVCA). Last year, U.S. billion into U.S.

Venture Capital 64

Venture Capital Funding Invest Capital 64

Xconomy

MAY 9, 2019

According to IPO research firm Renaissance Capital , 47 IPOs have priced so far this year across all sectors, down 27 percent compared to the same period in 2018. Five biotechs priced their IPOs and at least one more is coming. Just as last year, healthcare IPOs lead the way.

Pricing 110

Pricing Research Capital Marketing 110

Xconomy

APRIL 9, 2018

View the Slideshow With the first quarter in the books, it’s time to step back and lay out Xconomy’s editorial map for the rest of the year.

News 86

News Education Conference Report 86

Xconomy

DECEMBER 26, 2018

The sector saw more big venture capital deals and acquisitions , while researchers kept plugging away on technology advances. software startups to reflect on the trends that defined the sector in 2018—and where things might be headed in 2019. It was an eventful year for the artificial intelligence industry. Meanwhile, A.I.

Artificial Inteligence 94

Artificial Inteligence Venture Capital Research Acquisition 94

Xconomy

MAY 26, 2020

Privately held biotech ViaCyte has banked $27 million, the majority an installment of cash from a tranched $80 million Series D financing round it closed in late 2018.

Help 131

Help Develop Development San Diego 131

Xconomy

APRIL 9, 2018

Venture capital investors poured more than $28.2 companies during the first three months of 2018—marking the strongest single quarter in at least a dozen years, according to the Venture Monitor Report released today by Seattle-based PitchBook and the National Venture Capital Association (NVCA). billion into U.S.

Venture Capital 74

Venture Capital Funding Capital Report 74

Xconomy

APRIL 10, 2018

Venture capital investors sank $547.2 million into 37 startup companies throughout San Diego County during the first three months of 2018, maintaining roughly the same level of venture funding seen in recent quarters, according to the Venture Monitor Report. It was almost 4 percent higher than the $526.7

San Diego 66

San Diego Venture Capital Funding Report 66

Xconomy

MARCH 28, 2019

billion in new capital Thursday as the company completed an IPO that set its market capitalization at $24.3 million shares at $72 apiece, according to Renaissance Capital —the top of a new range that Lyft originally set at $62 to $68. billion at the time of its last fundraising in mid-2018. Lyft sold 30.8

Mobile 57

Mobile Capital Report Marketing 57

Xconomy

OCTOBER 17, 2019

Atomico, a European venture capital firm, has helped persuade Cambridge, UK-based Healx to return to the capital market a year earlier than anticipated. The biotech has just raised $56 million in Series B funding to bankroll its mission to use AI and machine learning to create affordable rare disease treatments.

Artificial Inteligence 52

Artificial Inteligence Venture Capital Platform Capital 52

Xconomy

JANUARY 28, 2019

Venture capital firms invest in potentially disruptive technologies with the hope of profit, then keep watch for further advances that could overtake their existing portfolio companies. All this is done while they guide startups through other external challenges such as fundraising droughts and overall market downturns.

Venture Capital 67

Venture Capital Marketing Guide Invest 67

Xconomy

MARCH 11, 2019

She succeeds Greg McKee, who served as president and CEO of the San Diego-based organization for five years before stepping down last month to start a venture capital fund. She’s also a partner in Ad Astra Ventures, an accelerator and venture fund for women-led startups she started in 2018 with Allison Long Pettine and Vidya Dinamani.

San Diego 67

San Diego Venture Capital Organization Capital 67

Xconomy

DECEMBER 14, 2018

The San Diego biotech company, which is testing an antibody discovery platform intended to speed products to patients with cancer and pancreatitis, said Thursday it has retained a local investment banking firm, Objective Capital Partners, to guide its sale. million in the first nine months of 2018 and $22.8 As of Sept.

San Diego 57

San Diego Guide Platform Sales 57

Xconomy

JULY 24, 2018

This fall, we are convening exemplary business leaders, investors, and far-seeing technologists for an in-depth exploration of the innovation ecosystem and its impact on the future. Come join us at our newest interactive conference, XCON: The Xconomy Conference on Technology and Transformation.

Conference 49

Conference Technology Google Sites 49

Both Sides of the Table

MARCH 23, 2015

One of the questions we discussed is, “How much capital should a startup raise?” ” Fred & I are both in agreement that there is a tension between capital constraints and creativity. Perhaps that’s rational capitalism at its extreme. Blogging is like Venus Fly Paper. This is classic Fred.

Venture Capital 150

Venture Capital Startup Writing Blogging 150

Xconomy

JANUARY 9, 2018

René Pinnell says he and his wife Selena Pinnell were “blown away” by the virtual reality projects their friends were creating in 2014, so they looked for an entrepreneurial niche that would allow them to support such artists. That year the couple, both trained in design, founded a startup in San Francisco, then called KaleidoscopeVR.

Content 71

Content Training Design Startup 71

Xconomy

APRIL 23, 2019

After a breakout year in 2017, the blockchain sector suffered a series of blows in 2018, from crashing cryptocurrency prices to increased regulatory scrutiny of crypto ventures and deepening skepticism about whether the technology was actually useful.

Report 98

Report Pricing Organization Technology 98

Xconomy

APRIL 27, 2020

The San Diego-based biotech, which started operations about 18 months ago, made its public debut in December 2018 with $42 million. On Monday Erasca—a portmanteau of “erase” and “cancer”— announced it had completed a Series B financing round jointly led by Arch Venture Partners and Cormorant Asset Management.

San Diego 76

San Diego Entrepreneur Develop Development 76

Xconomy

JANUARY 24, 2019

million in seed—in 2018 to advance its growing suite of products, digitized. The team at Trust & Will, a San Diego-based startup founded in October of 2017, is betting that a good chunk of those people would shell out some money to outline an estate plan if the process were cheaper and easier.

San Diego 73

San Diego Seed Funding Funding Startup 73

Xconomy

JANUARY 8, 2019

When we have a chance to view it from a distance, the year 2018 may be seen as a period when innovations in a number of technological fields came together to transform not only the future of computing, but also the very structure of the Internet.

Artificial Inteligence 62

Artificial Inteligence Demand Software Development Software 62

Xconomy

MARCH 2, 2018

It’s early yet in 2018, but the current count could put life-sciences companies on pace to bust past last year’s $17.6 By our count, investors put more than $800 million into life-sciences startups in four days. The money came from a wide range of backers, not just traditional biotech venture firms. Elsewhere, the U.S.

Funding 52

Funding Report Startup Venture Capital 52

Both Sides of the Table

AUGUST 20, 2015

We love capital efficiency until we love land grabs until we abhor over funding until we get huge payouts and ring the bell for more funding until we attract every non-VC on the planet to invest in startups until it crashes and we start the cycle all over again none the wiser. blog here ). VC funding. I see it in many young pups.

Funding 150

Funding Venture Capital Startup Marketing 150

Xconomy

JANUARY 10, 2019

Yet in 2018, perceptions about these dominant companies often reflected uneasiness and doubt—and for some, so did their stock performance. The market caps of some of the most successful tech titans reach as high as $1 trillion.

Platform 43

Platform Marketing Company Companies 43

Xconomy

DECEMBER 7, 2017

Proceeds will be used to advance Metacrine’s lead drug candidate, MET409, into first-in-human studies during the first half of 2018. Initial studies should be completed by the end of the year, the San Diego-based company said.

San Diego 49

San Diego Study Develop Development 49

Xconomy

DECEMBER 21, 2018

Before you fly off, or drive, or simply unplug, check out our preview of what could be next year’s top clinical studies; the tumult in big pharma’s on again-off again relationship with consumer healthcare; big names on the move in the nation’s capital; and a flurry of year-end deals. Happy holidays, everyone.

Pricing 73

Pricing Sales Study News 73

Xconomy

OCTOBER 30, 2018

Facebook (NASDAQ: FB ) shares gained nearly 3 percent Tuesday, and ticked up further in after-hours trading following the release of a third quarter earnings report that showed some strengths as well as shortfalls. election campaigns.

Social Media 51

Social Media Report Media San Diego 51

Xconomy

JULY 31, 2020

Bain Capital and Pfizer (NYSE: PFE ) launched it in 2018 with neuroscience compounds from the pharma giant’s labs. If you’ve never heard of Arya (NASDAQ: ARYBU ), it’s a shell company that Perceptive Advisors formed specifically to serve as a vehicle to take a private company public. Cerevel is young, but it’s pretty far along.

Pricing 72

Pricing Acquisition Capital Marketing 72

Xconomy

JULY 19, 2019

But when the financial oversight council published its 2018 annual report, it concluded that volatility in the cryptocurrency. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Pricing 89

Pricing Report Invest Venture Capital 89

Xconomy

JANUARY 4, 2019

In 2018, my Exome colleagues and I published hundreds of stories about health, medicine, the biopharma industry, government policy, and more. You’ll find a few of our favorite stories in this review of some of the year’s best from across the Xconomy network.

Pricing 69

Pricing Email Networking Silver Lake 69

Xconomy

JANUARY 15, 2019

As Xconomy’s editors looked back at the year just passed, we asked technology leaders to comment on the trends they’d observed in 2018, and the developments they expected in 2019.

.Net 65

.Net Technology Develop Development 65

Xconomy

OCTOBER 19, 2017

From Portland to Pittsburgh, it’s likely that every city in the U.S. with more than 1 million people has made its case to Amazon to locate the company’s second headquarters there. At least, hopefully they have already, because today—if you haven’t heard—was the deadline to apply.

Develop 82

Develop Development Software Development San Diego 82

Xconomy

JANUARY 4, 2019

In 2018, geopolitical events—in particular, President Donald Trump’s hard-line stances on trade and immigration, and the repeal of net neutrality rules—were top of mind for several business executives we interviewed recently.

.Net 102

.Net San Diego Startup Develop 102

Xconomy

MAY 26, 2017

Team Trump unveiled its 2018 federal spending proposal—the so-called “ skinny budget ”—with health and science in the crosshairs.

Marketing 56

Marketing Product San Diego Conference 56

TechCrunch LA

NOVEMBER 4, 2019

First it was street-style photography, then came the launch of her popular fashion blog WeWoreWhat. Bain Capital Ventures' Jamison Hill. The company plans to give creators and influencers more independence from existing platforms by allowing them access to funding from a team well-versed in their unique capital needs.

Platform 170

Platform Marketing Tool Venture Capital 170

Xconomy

SEPTEMBER 7, 2017

Amazon will pick the city in 2018. Amazon sent cities across North America into a frenzy Thursday after announcing plans to build a second headquarters outside of Seattle, bringing with it tens of thousands of jobs and billions of dollars in economic development benefits. Mexico is also part.

Commerce 76

Commerce Develop Development Software Development 76

Xconomy

AUGUST 16, 2019

billion in 2018, and Novartis reportedly knew but failed to report it to the FDA before the agency approved Zolgensma in May. We learned last week that the FDA was investigating Novartis for manipulating animal data related to its $2 million-a-dose gene therapy Zolgensma. The activity took place at AveXis, the firm Novartis bought for $8.7

Report 63

Report Activity San Diego Study 63